This website is for U.S. residents only. Residents of Canada, please visit: https://ponstherapy.ca.

For general inquiries, call 1 800-211-9136 or ponsinquiries@bionessmedical.com.

Approach MS gait challenges differently with PoNS Therapy®

Approach MS gait challenges differently with PoNS Therapy® If walking is one of your biggest challenges with multiple sclerosis (MS), you’re not alone—over 70% of people with MS experience trouble with their gait (ability to walk). Yet, treatments that specifically and effectively target this problem remain limited. PoNS® is a non-surgical treatment option that induces […]

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study January 22, 2025 at 7:00 AM EST –PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement […]

Get Back In Step With Life in 2025…with PoNS®!

Get Back In Step With Life in 2025…with PoNS®! As the year winds down, emotions can be mixed—especially if you’re living with multiple sclerosis (MS) and thinking about how to prioritize your physical health and overall well-being in the new year. If you’re ready to Get Back In Step With Life in 2025, now is […]

2024 Round-Up: PoNS® Takes Big Steps Forward

2024 Round-Up: PoNS® Takes Big Steps Forward As the year comes to a close, we’re reflecting on the progress we’ve made and the meaningful impact PoNS® has had on individual lives. Read on for a recap of this year’s highlights! Amplifying the voices of people living with MS Real-life PoNS users Kerrie Walters and US Veteran […]

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece — Reimbursement Determination for the PoNS Mouthpiece (HCPCS code A4594) set at $2,963.30 on Lump Sum Payment to be challenged by Helius — — National Reimbursement Payment Determination from CMS for its PoNS Controller Deferred […]

A Day With PoNS

A Day With PoNS® You might already know that PoNS Therapy® is used to improve walking ability for people with multiple sclerosis (MS)—but did you know that it can be tailored to your specific needs and schedule? PoNS Therapy is a combination of physical therapy (PT) and the use of the PoNS® (Portable Neuromodulation Stimulator) […]

How PoNS® Brings Physical Therapy to the Next Level

How PoNS® Brings Physical Therapy to the Next Level PoNS, the Portable Neuromodulation Stimulator, is an orally-applied therapy proven to increase walking ability for people with multiple sclerosis (MS). PoNS must be used in conjunction with physical therapy (PT). Together, PoNS and PT are referred to as PoNS Therapy®. Boost PT with PoNS and Get […]

PoNS® Real Stories: How Mariska Improved Her Ability to Walk

PoNS® Real Stories: How Mariska Improved Her Ability to Walk PoNS is proud to improve walking ability for those with multiple sclerosis (MS), so they can Get Back In Step With Life. Mariska, a PoNS-user with MS, spoke to us about her own PoNS journey. Read on to see how PoNS enhanced her mobility, and […]

By submitting this form, you agree to receive communications by text message, phone and email regarding information about products and services from Bioness Medical. You may opt out by replying STOP or ask for more information by replying HELP. Message frequency varies. Message and data rates may apply. You may review our Privacy Policy to learn how your data is used. You may choose unsubscribe and choose not to receive further information from Bioness Medical by emailing ponsinquiries@bionessmedical.com

IMPORTANT SAFETY INFORMATION

No serious adverse events related to the PoNS device were reported in the MS RCTs or in use in clinical rehabilitation settings to treat balance and gait disorders.

Some individuals have reported headaches, fatigue, and excess salivation. Excess salivation during training sessions often occurs but generally improves as patients get used to wearing the mouthpiece.

Indication
The PoNS® device is indicated for use as a short term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis and is to be used as an adjunct to a supervised therapeutic exercise program for adults 22 years of age and over by prescription only.

Contraindications
The PoNS® device delivers electrical stimulation directly to the surface of the tongue. Precautions for use are similar to those for transcutaneous electrical nerve stimulation (TENS).

Electrical stimulation should not be used:

  • If there is an active or suspected malignant tumor
  • In areas of recent bleeding or open wounds
  • In areas that lack normal sensation

The PoNS® has not been tested on, and thus should not be used by individuals who are pregnant. Do not use the PoNS® if you are sensitive to nickel, gold or copper.

Use with caution
Electrical stimulation should only be used after seeking professional medical advice, and with caution in patients with any of the following:

  • Implanted electronic devices, including:
    • Cardiac pacemakers
    • Cardioverter defibrillators
    • Deep Brain Stimulators
    • Vagal Nerve Stimulators
    • Sacral nerve stimulators
    • Cochlear Implants
  • Metal in the mouth (e.g. piercings, braces, retainers, or other orthodontic appliance)
  • Seizure disorders
  • Epilepsy

Ready to get started with PoNS?

Patients who are seeking more information on how to get PoNS can email us at ponsinquiries@bionessmedical.com, or fill out our contact form:
Contact Us